The Valley Desk

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPublished

Nivolumab Plus Ipilimumab as First-Line Treatment for Patients With Metastatic Non-Small Cell Lung Cancer: Final, 7.5-Year Outcomes From CheckMate 227

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple Health. Affiliation source

Publication record

Type
Article
Venue
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published
Subject terms
Immunotherapy; Ipilimumab; Metastatic Nsclc; Nivolumab; Immune Checkpoint Inhibitor
PubMed ID
43057628
Added to directory
Source checked

Report a correction or request removal